Centenial Surgical Suture Ltd
Centenial Surgical Suture Ltd Live Price Chart
Performance
| Previous Close | ₹ 82.51 |
| High | ₹ 81 |
| Volume | 45 |
| 52W Range | ₹ 76.27 - ₹ 189 |
| Open | ₹ 81 |
| Low | ₹ 81 |
| Market Cap | ₹ 37 Cr |
Centenial Surgical Suture Ltd Technicals
| 20 Day | ₹ 90.307 |
| 50 Day | ₹ 91.992 |
| 100 Day | ₹ 95.517 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Centenial Surgical Suture Ltd Fundamentals
| ROCE | 2.136 |
| P/E Ratio | -13.410 |
| P/B Ratio | 1.100 |
| Industry P/E | 1.100 |
| Debt to Equity | 80.106 |
| ROE | -7.722 |
| EPS | -6.040 |
| Dividend Yield | 0.000 |
| Book Value | 73.399 |
| Face Value | 10.000 |
Centenial Surgical Suture Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 53.6363 | 51.3149 | 52.7847 | 44.4712 | 37.0256 |
| Total Expenses | 55.254 | 50.042 | 51.3218 | 43.3967 | 35.4957 |
| Profit After Tax | -1.4636 | 1.1343 | 0.8859 | 0.6271 | 0.9618 |
Centenial Surgical Suture Ltd Shareholding Pattern
| Promoter Holdings | 46.888 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 50.687 % |
| Others - | 2.425 % |
About Centenial Surgical Suture Ltd
Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India. The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes. It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons. Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company. Within the cardiovascular division, Centenial offers a wide range of product codes which includes over 300 codes produced catalogue that cover applications for CABG. Company enjoys deep manufacturing capabilities and know-how in Cardiovascular Sutures, materials and atraumatic needles, that makes it a trusted partner. Centenial competes with many domestic and foreign medical device companies ranging from small start-up enterprises that might sell only a single or limited number of competitive products or compete only in a specific market segment, to c ...
